Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TNFSF15 Antikörper

Dieses Anti-TNFSF15-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von TNFSF15 in IHC (f). Geeignet für Human.
Produktnummer ABIN6938629

Kurzübersicht für Rekombinanter TNFSF15 Antikörper (ABIN6938629)

Target

Alle TNFSF15 Antikörper anzeigen
TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 108
  • 36
  • 18
  • 5
  • 4
  • 4
  • 4
Human

Wirt

  • 79
  • 31
  • 3
  • 1
Maus

Klonalität

  • 63
  • 48
  • 3
Monoklonal

Konjugat

  • 56
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TNFSF15 Antikörper ist unkonjugiert

Applikation

  • 68
  • 44
  • 27
  • 27
  • 26
  • 21
  • 13
  • 13
  • 11
  • 7
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

RVEGI-1283
  • Spezifität

    VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human full-length VEGI protein

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen or prostate.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

    Andere Bezeichnung

    TNFSF15

    Hintergrund

    TNF ligand-related molecule 1 (TL1A), Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15), Vascular endothelial growth inhibitor 192a, Vascular endothelial growth inhibitor (VEGI), VEGI192A,TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor)
    Cellular localisation: Secreted and Cell Surface

    Molekulargewicht

    22kDa

    Gen-ID

    9966, 241382

    UniProt

    O95150

    Pathways

    Positive Regulation of Endopeptidase Activity, Autophagie
Sie sind hier:
Chat with us!